Services


 

  • Upstream Process Development (USP)
    • Mammalian cell culture process development for production of monoclonal antibodies and recombinant protein
    • Clone Selection based on the productivity and quality
    • Single cell selection
    • Cell line adaptation (Serum free or suspension)
    • Master cell bank (MCB) & working cell bank (WCB) generation
    • Media development (chemically defined)
    • Development of nutrients & feed strategy to increase culture growth and productivity (animal component free)
    • Scale up studies
    • Development of key aspects of monitoring & control technology
    • Scale down model for process characterization
    • Design of experiments (DOE) for optimization
    • Process Analytical Technology (PAT) Development
    • Production at pilot scale for preclinical and early clinical stage studies
    • Transfer technology and support
  • Downstream Process Development (DSP)
    • Development of recombinant therapeutic proteins and monoclonal antibody purification process
    • Prefiltration process development (right pre filtration selection to reduce the bioburden)
    • Chromatographic separation
    • Ultrafiltration and diafiltration development
    • Virus clearance studies
    • Scale down model for process characterization
  • cGMP Manufacturing service
    • iBG-Izmir will provide service to biotech industries for the production of recombinant proteins in bulk for their clinical trials and commercial use. Initially we will be able to provide up to 200L production capacity and in later phase up to 1000L. GMP facility is under construction will be ready to provide service in 2017

 

June 2018
M T W T F S S
« May    
 123
45678910
11121314151617
18192021222324
252627282930